A Phase 3 Study of Viloxazine ER Capsules in Korean Children and Adolescents With ADHD

Clinical trial NCT07678827 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07678827
Sponsor: Alvogen Korea
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Attention Deficit Hyperactivity Disorder Attention-Deficit / Hyperactivity Disorder ADHD

Start date: 2026-07-01
Primary completion: 2027-09-01
Enrollment: 156

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.